BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6422167)

  • 1. Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences.
    Payne BA; Pierre RV
    Mayo Clin Proc; 1984 Feb; 59(2):123-5. PubMed ID: 6422167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count.
    Lippi U; Schinella M; Nicoli M; Modena N; Lippi G
    Haematologica; 1990; 75(1):38-41. PubMed ID: 2110927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
    Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
    Thromb Haemost; 1995 Mar; 73(3):506-13. PubMed ID: 7545322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia.
    Bartels PC; Schoorl M; Lombarts AJ
    Scand J Clin Lab Invest; 1997 Nov; 57(7):629-36. PubMed ID: 9397495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EDTA-dependent pseudothrombocytopaenia: a 12-month epidemiological study.
    Vicari A; Banfi G; Bonini PA
    Scand J Clin Lab Invest; 1988 Oct; 48(6):537-42. PubMed ID: 3146133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Correction of Spurious Low Platelet Counts due to EDTA-Dependent Pseudothrombocytopenia.
    Lin J; Luo Y; Yao S; Yan M; Li J; Ouyang W; Kuang M
    J Clin Lab Anal; 2015 Sep; 29(5):419-26. PubMed ID: 25425098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact.
    Lippi G; Plebani M
    Clin Chem Lab Med; 2012 Aug; 50(8):1281-5. PubMed ID: 22868791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EDTA-induced pseudothrombocytopenia].
    Foresti V; Parisio E; Tronci M; Casati O; Zubani R; Pedretti D
    Recenti Prog Med; 1990 Oct; 81(10):661-2. PubMed ID: 2127122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin can be added to blood to reduce the fall in platelet count.
    Zhou X; Wu X; Deng W; Li J; Luo W
    Am J Clin Pathol; 2011 Oct; 136(4):646-52. PubMed ID: 21917689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of automated platelet clump count in the screening for ethylene diamine tetraacetic acid-dependent pseudothrombocytopenia.
    Wu W; Guo Y; Zhang L; Cui W; Li W; Zhang S
    Chin Med J (Engl); 2011 Oct; 124(20):3353-7. PubMed ID: 22088534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.
    Schuff-Werner P; Steiner M; Fenger S; Gross HJ; Bierlich A; Dreissiger K; Mannuß S; Siegert G; Bachem M; Kohlschein P
    Br J Haematol; 2013 Sep; 162(5):684-92. PubMed ID: 23808903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant spuriously elevated white blood cell count, a previously underestimated phenomenon in EDTA-dependent pseudothrombocytopenia.
    Xiao Y; Xu Y
    Platelets; 2015; 26(7):627-31. PubMed ID: 25275874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro.
    Kozak M; Dovc T; Rozman P; Blinc A
    Wien Klin Wochenschr; 2000 Feb; 112(3):138-41. PubMed ID: 10729966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDTA-dependent pseudothrombocytopenia in a child.
    Akbayram S; Dogan M; Akgun C; Caksen H; Oner AF
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):494-6. PubMed ID: 20530050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of platelet aggregation in six cases of EDTA-dependent pseudothrombocytopenia].
    Shimasaki A; Kato T; Ozaki Y
    Rinsho Ketsueki; 1994 Jun; 35(6):529-34. PubMed ID: 8078186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K).
    Ohnuma O; Shirata Y; Miyazawa K
    J Clin Pathol; 1988 Aug; 41(8):915-7. PubMed ID: 3139717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudothrombocytopenia: incidence, causes and methods of detection].
    García Suárez J; Merino JL; Rodríguez M; Velasco A; Moreno MC
    Sangre (Barc); 1991 Jun; 36(3):197-200. PubMed ID: 1948538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.
    Lombarts AJ; de Kieviet W
    Am J Clin Pathol; 1988 May; 89(5):634-9. PubMed ID: 3128946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient appearance of EDTA dependent pseudothrombocytopenia in a patient with 2019 novel coronavirus pneumonia.
    Li H; Wang B; Ning L; Luo Y; Xiang S
    Platelets; 2020 Aug; 31(6):825-826. PubMed ID: 32367749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pseudothrombocytopenia caused by ethylenediaminetetraacetic acid (EDTA) (case report)].
    Putarek K; Vuk T; Soldo D; Sarlija D; Grgicevic D; Jaksić B
    Lijec Vjesn; 1997 Jan; 119(1):19-21. PubMed ID: 9213726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.